πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

ALMIRALL S.P.A Patents

Full USPTO pharma patent portfolio for ALMIRALL S.P.A β€” grant dates, expiration, and drug cross-links.

Patents
308
Expiring ≀24m
14

Quick answer

ALMIRALL S.P.A has 308 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 14 expire within 24 months β€” use filters for patent-cliff planning.

Page 5 of 7

  1. US 8697730

    5-lipoxygenase activating protein (FLAP) inhibitor

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8691852

    Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors

    Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8664220

    Polycyclic compounds as lysophosphatidic acid receptor antagonists

    Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8642751

    MicroRNA inhibitors comprising locked nucleotides

    Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8642076

    Lipid containing formulations

    Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8592464

    Nitric oxide furoxan derivative compounds endowed with antitumoral activity

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8592402

    Compounds as lysophosphatidic acid receptor antagonists

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8575123

    Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components

    Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8569320

    Topical composition for the treatment of actinic keratosis

    Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8563731

    Mesylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]jamino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the Ξ²2 adrenergic receptor

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8541587

    Lysophosphatidic acid receptor antagonists

    Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8536165

    Azabiphenylaminobenzoic acid derivatives as DHODH inhibitors

    Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8524908

    Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8524748

    Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8513279

    Quinuclidine derivatives and medicinal compositions containing the same

    Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8501943

    Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor

    Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8501959

    Cycloalkane[B]indole antagonists of prostaglandin D2 receptors

    Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8497381

    Antagonists of prostaglandin D2 receptors

    Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8455499

    Alkyne antagonists of lysophosphatidic acid receptors

    Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8450341

    Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors

    Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8445694

    Hydrazonopyrazole derivatives and their use as therapeutics

    Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8440707

    Antagonists of lysophosphatidic acid receptors

    Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8426449

    Aminoalkylphenyl antagonists of prostaglandin D2 receptors

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8420669

    Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the BETA2 adrenergic receptor

    Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8410272

    Pyrazolylbenzothiazole derivatives and their use as therapeutic agents

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8399666

    5-lipoxygenase-activating protein (FLAP) inhibitors

    Expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8383654

    Heterocyclic antagonists of prostaglandin D2 receptors

    Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8378107

    Heteroaryl antagonists of prostaglandin D2 receptors

    Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8362044

    N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

    Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8343463

    Optical imaging agent

    Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8338484

    N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8334294

    4,8-diphenyl-polyazanaphthalene derivatives

    Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8283342

    Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the Ξ²2 adrenergic receptor

    Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8273780

    Polycyclic antagonists of lysophosphatidic acid receptors

    Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8258122

    3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives

    Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8258308

    Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors

    Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8247602

    Antagonists of prostaglandin D2 receptors

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8242177

    Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the Ξ²2 adrenergic receptor

    Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8242145

    Cyclic diaryl ether compounds as antagonists of prostaglandin D2 receptors

    Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8217066

    Compounds as lysophosphatidic acid receptor antagonists

    Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8178679

    Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the Ξ²2 adrenergic receptors

    Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8168678

    N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

    Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8129405

    Quinuclidine derivatives and medicinal compositions containing the same

    Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8071807

    Antagonists of prostaglandin D2 receptors

    Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8067445

    N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

    Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8058300

    Polycyclic antagonists of lysophosphatidic acid receptors

    Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8049015

    Heteroaryl antagonists of prostaglandin D2 receptors

    Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8048902

    Antagonists of lysophosphatidic acid receptors

    Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does ALMIRALL S.P.A have?

308 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do ALMIRALL S.P.A patents expire?

14 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.